Parexel Announces Significant Recognition for Diversity and Workplace Culture in Asia/Pacific Region; Reaches Significant Company Milestone in Japan

2 years ago

Recent achievements showcase company’s leadership as CRO Partner and Employer of Choice in the Asia/Pacific regionBOSTON and DURHAM, N.C., Nov. 29,…

Chiesi USA Announces Publication of Health Economics Analysis of Selective Early Rescue Surfactant Administration vs. Standard Surfactant Administration for Premature Infants with Respiratory Distress Syndrome

2 years ago

This cost-consequence analysis suggests selective early rescue surfactant administration strategies are associated with a lower healthcare burden in premature infants…

Shineco, Inc. Attends MEDICA 2022 Düsseldorf Germany

2 years ago

Shineco, Inc. Dr. Marvin Liu (second person from the left) introduced products to customers on siteBEIJING, Nov. 29, 2022 (GLOBE…

Mountain Valley MD Provides Business Update, Focus On Commercialization Phase

2 years ago

TORONTO, Nov. 29, 2022 (GLOBE NEWSWIRE) -- Mountain Valley MD Holdings Inc. (the “Company” or “MVMD”) (CSE: MVMD) (OTCQB: MVMDF)…

Biora Therapeutics Licenses Preeclampsia Rule-Out Test for Commercial Development

2 years ago

Avero Diagnostics to Develop and Commercialize, Enabling Potential Future Revenue for Biora TherapeuticsSAN DIEGO, Nov. 29, 2022 (GLOBE NEWSWIRE) --…

Assure to Attend Investor Conferences in December 2022

2 years ago

DENVER, Nov. 29, 2022 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative…

ProSomnus Reports Third Quarter Financial Results and Provides Corporate Update

2 years ago

Generated record quarterly revenues, and expects merger with Lakeshore Acquisition I Corp. to close in the fourth quarter of 2022…

Nanomix Enters into Distribution Agreement for the eLab System with Gepa Srl in Italy

2 years ago

SAN LEANDRO, Calif., Nov. 29, 2022 (GLOBE NEWSWIRE) -- Nanomix Corporation (OTCQB: NNMX) (“Nanomix” or the “Company”), a leader in…

Interim Data from Ambrx’s Study of ARX788 selected for Spotlight Poster Discussion at the 2022 San Antonio Breast Cancer Symposium

2 years ago

Investigators to present efficacy and safety data of ARX788 treatment in patients with HER2+ metastatic breast cancer who have progressed…

Mushrooms, Inc. Announces Name and Ticker Symbol Change on OTC Markets to “MSRM”

2 years ago

ESTERO, Fla., Nov. 29, 2022 (GLOBE NEWSWIRE) -- Mushrooms Inc. (OTC: MSRM) (the “Company”), formerly Marijuana Strategic Ventures, Inc., is…